FDA — authorised 23 March 2012
- Application: NDA202813
- Marketing authorisation holder: TEVA BRANDED PHARM
- Local brand name: QNASL
- Indication: AEROSOL, METERED — NASAL
- Status: approved
🇺🇸 BDP HFA in United States
FDA authorised BDP HFA on 23 March 2012
Marketing authorisation
Other Respiratory / Pulmonology approved in United States
Frequently asked questions
Is BDP HFA approved in United States?
Yes. FDA authorised it on 23 March 2012.
Who is the marketing authorisation holder for BDP HFA in United States?
TEVA BRANDED PHARM holds the US marketing authorisation.